Advanced Medical Solutions Group plc
AMS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £178 | £126 | £124 | £109 |
| % Growth | 40.7% | 1.5% | 14.5% | – |
| Cost of Goods Sold | £85 | £56 | £56 | £52 |
| Gross Profit | £83 | £70 | £69 | £56 |
| % Margin | 46.6% | 55.6% | 55.2% | 51.7% |
| R&D Expenses | £5 | £6 | £4 | £4 |
| G&A Expenses | £69 | £51 | £47 | £37 |
| SG&A Expenses | £67 | £52 | £49 | £38 |
| Sales & Mktg Exp. | £2 | £2 | £2 | £1 |
| Other Operating Expenses | £9 | -£7 | -£5 | -£4 |
| Operating Expenses | £81 | £51 | £49 | £38 |
| Operating Income | £10 | £19 | £25 | £23 |
| % Margin | 5.9% | 15% | 20% | 21.2% |
| Other Income/Exp. Net | -£1 | £2 | £1 | -£1 |
| Pre-Tax Income | £10 | £21 | £26 | £22 |
| Tax Expense | £3 | £5 | £6 | £5 |
| Net Income | £7 | £16 | £20 | £17 |
| % Margin | 4% | 12.6% | 16.4% | 16.1% |
| EPS | 0.033 | 0.074 | 0.094 | 0.081 |
| % Growth | -55% | -21.9% | 16.3% | – |
| EPS Diluted | 0.033 | 0.073 | 0.093 | 0.08 |
| Weighted Avg Shares Out | 214 | 216 | 217 | 216 |
| Weighted Avg Shares Out Dil | 218 | 219 | 219 | 218 |
| Supplemental Information | – | – | – | – |
| Interest Income | £2 | £2 | £1 | £0 |
| Interest Expense | £4 | £0 | £1 | £1 |
| Depreciation & Amortization | £16 | £11 | £9 | £9 |
| EBITDA | £30 | £31 | £35 | £32 |
| % Margin | 16.7% | 24.9% | 28.1% | 29.1% |